Inhibition of plasma membrane monoamine transporters by β- ketoamphetamines

European Journal of Pharmacology

Volumn 381, Issue 1, 1999, Pages 63-69

  Cozzi, Nicholas V ^a,b   Sievert, Michael K ^b   Shulgin, Alexander T ^c   Jacob III, Peyton ^d   Ruoho, Arnold E ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c 1483 Shulgin Road ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); MDMA (3,4 methylenedioxymethamphetamine); Methamphetamine; Methcathinone; Monoamine transporter; Vesicle transporter (VMAT2)

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; CARRIER PROTEIN; METHAMPHETAMINE; METHCATHINONE; MONOAMINE; NORADRENALIN; SEROTONIN;

ANIMAL CELL; ARTICLE; CHROMAFFIN GRANULE; DRUG POTENCY; DRUG STRUCTURE; DRUG UPTAKE; GENETIC TRANSFECTION; GLIA CELL; HUMAN; HUMAN CELL; INHIBITION KINETICS; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

3,4-METHYLENEDIOXYAMPHETAMINE; ANIMALS; CATTLE; CELL MEMBRANE; CHROMAFFIN CELLS; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHAMPHETAMINE; NEUROPEPTIDES; NOREPINEPHRINE; PROPIOPHENONES; SEROTONIN; TRITIUM; TUMOR CELLS, CULTURED; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS;

EID: 0032856963     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00538-5     Document Type: Article

References (24)

1. Anonymous, 1993. Federal Register 58, 53404-53406.
2. Cinquanta M., Ratovitski T., Crespi D., Gobbi M., Mennini T., Simantov R. Carrier-mediated serotonin release induced by d-fenfluramine: studies with human neuroblastoma cells transfected with a rat serotonin transporter. Neuropharmacology. 36:1997;803-809.
3. Dal Cason T.A. The characterization of some 3,4-methylenedioxycathinone (MDCATH) homologs. Forensic Sci. Int. 87:1997;9-53.
4. Dal Cason T.A., Young R., Glennon R.A. Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs. Pharmacol. Biochem. Behav. 58:1997;1109-1116.
5. Glennon R.A., Yousif M., Naiman N., Kalix P. Methcathinone: a new and potent amphetamine-like agent. Pharmacol. Biochem. Behav. 26:1987;547-551.
6. Gygi M.P., Gibb J.W., Hanson G.R. Methcathinone: an initial study of its effects on monoaminergic systems. J. Pharmacol. Exp. Ther. 276:1996;1066-1072.
7. Gygi M.P., Fleckenstein A.E., Gibb J.W., Hanson G.R. Role of endogenous dopamine in the neurochemical deficits induced by methcathinone. J. Pharmacol. Exp. Ther. 283:1997;1350-1355.
8. Huang X., Marona-Lewicka D., Nichols D.E. p-Methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent. Eur. J. Pharmacol. 229:1992;31-38.
9. Hyde J.F., Browning E., Adams R. Synthetic homologs of DL-ephedrine. J. Am. Chem. Soc. 50:1928;2287-2292.
10. 3H]dopamine release from superfused rat brain slices. Eur. J. Pharmacol. 132:1986;269-276.
11. 3H]Monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues. Eur. J. Pharmacol. 200:1991;9-16.
12. Kaminski B.J., Griffiths R.R. Intravenous self-injection of methcathinone in the baboon. Pharmacol. Biochem. Behav. 47:1994;981-983.
13. L'Italien, Y.J., Park, H., Rebstock, M.C., 1957. Methylaminopropiophenone compounds and methods for producing the same. US Patent # 2802865.
14. 3H-5-hydroxytryptamine. Pharmacol. Biochem. Behav. 38:1991;505-512.
15. Nichols D.E., Marona-Lewicka D., Huang X., Johnson M.P. Novel serotonergic agents. Drug Des. Discov. 9:1993;299-312.
16. Paton D.M. Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria. Br. J. Pharmacol. 49:1973;614-627.
17. Rosen D.S. Methcathinone. J. Adoles. Health. 14:1993;426.
18. Rudnick G., Wall S.C. The molecular mechanism of ecstasy [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. U.S.A. 89:1992;1817-1821.
19. Rudnick G., Wall S.C. p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry. 31:1992;6710-6718.
20. Rudnick G., Wall S.C. Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters. Mol. Pharmacol. 43:1993;271-276.
21. Schuldiner S., Steiner-Mordoch S., Yelin R., Wall S.C., Rudnick G. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. Mol. Pharmacol. 44:1993;1227-1231.
22. 3H]monoamines into synaptosomes from different regions of rat brain. Biochem. Pharmacol. 36:1987;2297-2303.
23. Sulzer D., Rayport S. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron. 5:1990;797-808.
24. Young R., Glennon R.A. Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex. Pharmacol. Biochem. Behav. 45:1993;229-231.